NCBGG provides state-of-the-art molecular testing for donor centers and patients they serve.
The purpose of the table is to document RHCE alleles that have been reported associated with a clinical presentation, be it altered antigen expression on the RBCs and/or antibody production in a patient.
Our knowledge of HDFN has evolved over time. Now, RHD genotyping is improving how we prevent the disease.
While relatively new, RHD genotyping has become an effective means of RhD classification without putting a financial burden on clinicians or healthcare facilities.
At this time, it may not be possible to perform RHD genotyping on all pregnant women and individuals receiving blood transfusions but is anticipated to be routine in the future. Currently, consider the following patient management tips.
While RhIG has reduced morbidity and mortality due to HDFN, excessive and unnecessary use poses ethical concerns. Learn how RHD genotyping can help.
Have samples to send to NCBGG for testing? Submit this request form.
Ship your patient samples in 4 easy steps.
Don't see what you need? Contact NCBGG for more info.
NCBGG provides the highest quality testing services for extended blood typing at lower cost for donor centers and the patients they serve to improve the practice of transfusion medicine, to develop the next generation of testing, and to train the next generation of leaders.
DNA-based testing for extended blood typing for donors and patients
Detailed red cell and platelet antigen profiles on patient and donor samples
Testing, Treatment and Management Options, including RhD and K typing
Precise Match products enhance patient care
Why Do Some Pregnant Women Type as Both Rh Positive & Rh Negative? Consistency is essential to quality healthcare, but current Rh typing methods are causing significant discrepancies that OB-GYNs need to address.